The silent epidemic of lymphogranuloma venereum inside the COVID-19 pandemic in Madrid, Spain, March 2020 to February 2021
Euro Surveill. 2021 May;26(18). doi: 10.2807/1560-7917.ES.2021.26.18.2100422.ABSTRACTDespite social distancing measures implemented in Madrid to prevent the propagation of SARS-CoV-2, a significant increase (57.1%; 28.5 to 38.5 cases/month) in cases of lymphogranuloma venereum was detected during the COVID-19 pandemic. This unusual scenario might have accelerated a shift in Chlamydia trachomatis (CT) epidemiology towards a higher proportion of L genotypes compared with non-L genotypes in CT-positive samples. Our data underscore the importance of surveillance of sexually transmitted infections during the pandemic, in partic...
Source: Euro Surveill - May 7, 2021 Category: Infectious Diseases Authors: Laura Mart ínez-García Mario Rodr íguez-Domínguez Clara Lejarraga Mar ía Concepción Rodríguez-Jiménez Jos é María González-Alba Teresa Puerta Matilde S ánchez-Conde Jos é Manuel Hermida Beatriz Romero-Hern ández Juan Carlos Gal án Source Type: research

Note from the editors: < em > Eurosurveillance < /em > , 1996 to 2021 - 25 years of public health impact
Euro Surveill. 2021 May;26(18). doi: 10.2807/1560-7917.ES.2021.26.18.2105061.NO ABSTRACTPMID:33960289 | DOI:10.2807/1560-7917.ES.2021.26.18.2105061 (Source: Euro Surveill)
Source: Euro Surveill - May 7, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Surveillance data for human leishmaniasis indicate the need for a sustainable action plan for its management and control, Greece, 2004 to 2018
We present surveillance data for visceral (VL) and cutaneous (CL) leishmaniasis for the period 2004 to 2018 in Greece to assess their public health importance.MethodsWe extracted data from the mandatory notification system to analyse separately imported and domestic cases of VL and CL. A case was defined by clinical manifestations compatible with VL or CL and laboratory confirmation.ResultsBetween 2004 and 2018, 881 VL (862 domestic, 19 imported) and 58 CL cases (24 domestic, 34 imported) were recorded. The mean annual notification rate of domestic VL was 0.5 per 100,000 (range: 0.12-1.43/100,000) with a statistically sign...
Source: Euro Surveill - May 7, 2021 Category: Infectious Diseases Authors: Myrsini Tzani Alicia Barrasa Annita Vakali Theano Georgakopoulou Kassiani Mellou Danai Pervanidou Source Type: research

Case series of four re-infections with a SARS-CoV-2 B.1.351 variant, Luxembourg, February 2021
We describe four SARS-CoV-2 re-infections with a B.1.351 variant in 2021, in healthcare workers (HCWs) previously infected in 2020, before detection of this variant in Europe. Cases live in France, near the border with Luxembourg, where variants B.1.351 and B.1.1.7 circulated. All work in the same hospital unit where a cluster of COVID 19 with B1.351 variant occurred, affecting patients and HCWs. Before the cluster onset, HCWs used surgical masks, as per recommendations. After cluster onset, HCWs used FFP2 masks.PMID:33960291 | DOI:10.2807/1560-7917.ES.2021.26.18.2100423 (Source: Euro Surveill)
Source: Euro Surveill - May 7, 2021 Category: Infectious Diseases Authors: Th érèse Staub Vic Arendt Esther Calvo Lasso de la Vega Pierre Braquet Christian Michaux Michel Kohnen Chantal Tsobo Tamir Abdelrahman Anke Wienecke-Baldacchino Jean-Hugues Francois Source Type: research

Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
Euro Surveill. 2021 Apr;26(17):2100420. doi: 10.2807/1560-7917.ES.2021.26.17.2100420.ABSTRACTData on effectiveness of the BioNTech-/Pfizer COVID-19 vaccine in real-world settings are limited. In a study of 6,423 healthcare workers in Treviso Province, Italy, we estimated that, within the time intervals of 14-21 days from the first and at least 7 days from the second dose, vaccine effectiveness in preventing SARS-CoV-2 infection was 84% (95% confidence interval (CI): 40-96) and 95% (95% CI: 62-99), respectively. These results could support the ongoing vaccination campaigns by providing evidence for targeted communication.PM...
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Massimo Fabiani Mauro Ramigni Valentina Gobbetto Alberto Mateo-Urdiales Patrizio Pezzotti Cinzia Piovesan Source Type: research

National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines
We described existing programmes and used multivariable regression to identify independent factors associated with having them.ResultsOf 194 WHO Member States, 120 (62%) reported having at least one adult immunisation programme. The Americas and Europe had the highest proportions of adult immunisation programmes, most commonly for hepatitis B and influenza vaccines (> 47% and> 91% of countries, respectively), while Africa and South-East Asia had the lowest proportions, with
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sarah R Williams Amanda J Driscoll Hanna M LeBuhn Wilbur H Chen Kathleen M Neuzil Justin R Ortiz Source Type: research

Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019
ConclusionThe immunity gaps found primarily in young HCW indicate a need for a screening and vaccination strategy for this group. Considering the poor correlation between self-reported immunity and seropositivity, efforts should be made to check HCW's immune status in order to identify those who would benefit from vaccination.PMID:33928900 | PMC:PMC8086246 | DOI:10.2807/1560-7917.ES.2021.26.17.2001167 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Marie-Louise von Linstow Alex Yde Nielsen Nikolai Kirkby Anna Eltvedt Thilde Nordmann Winther Allan Bybeck Nielsen Didi Bang Anja Poulsen Source Type: research

No country or continent is on its own in the ongoing COVID-19 pandemic
Euro Surveill. 2021 Apr;26(17):2100430. doi: 10.2807/1560-7917.ES.2021.26.17.2100430.NO ABSTRACTPMID:33928901 | PMC:PMC8086248 | DOI:10.2807/1560-7917.ES.2021.26.17.2100430 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Kari Johansen Hanna Nohynek Source Type: research

Socioeconomic deprivation is inversely associated with measles incidence:  a longitudinal small-area analysis, Germany, 2001 to 2017
ConclusionSocioeconomic deprivation in Germany, one of Europe's most populated countries, is inversely associated with measles incidence. This association persists after demographic and spatiotemporal factors are considered. The social, spatial and temporal patterns of elevated risk require targeted public health action and policy to address the complexity underlying measles epidemiology.PMID:33928902 | PMC:PMC8086244 | DOI:10.2807/1560-7917.ES.2021.26.17.1900755 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sven Rohleder Christian Stock Kayvan Bozorgmehr Source Type: research

Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100420.ABSTRACTData on effectiveness of the BioNTech-/Pfizer COVID-19 vaccine in real-world settings are limited. In a study of 6,423 healthcare workers in Treviso Province, Italy, we estimated that, within the time intervals of 14-21 days from the first and at least 7 days from the second dose, vaccine effectiveness in preventing SARS-CoV-2 infection was 84% (95% confidence interval (CI): 40-96) and 95% (95% CI: 62-99), respectively. These results could support the ongoing vaccination campaigns by providing evidence for targeted communication.PMID:33928...
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Massimo Fabiani Mauro Ramigni Valentina Gobbetto Alberto Mateo-Urdiales Patrizio Pezzotti Cinzia Piovesan Source Type: research

National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines
We described existing programmes and used multivariable regression to identify independent factors associated with having them.ResultsOf 194 WHO Member States, 120 (62%) reported having at least one adult immunisation programme. The Americas and Europe had the highest proportions of adult immunisation programmes, most commonly for hepatitis B and influenza vaccines (> 47% and> 91% of countries, respectively), while Africa and South-East Asia had the lowest proportions, with
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sarah R Williams Amanda J Driscoll Hanna M LeBuhn Wilbur H Chen Kathleen M Neuzil Justin R Ortiz Source Type: research

Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019
ConclusionThe immunity gaps found primarily in young HCW indicate a need for a screening and vaccination strategy for this group. Considering the poor correlation between self-reported immunity and seropositivity, efforts should be made to check HCW's immune status in order to identify those who would benefit from vaccination.PMID:33928900 | DOI:10.2807/1560-7917.ES.2021.26.17.2001167 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Marie-Louise von Linstow Alex Yde Nielsen Nikolai Kirkby Anna Eltvedt Thilde Nordmann Winther Allan Bybeck Nielsen Didi Bang Anja Poulsen Source Type: research

No country or continent is on its own in the ongoing COVID-19 pandemic
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100430.NO ABSTRACTPMID:33928901 | DOI:10.2807/1560-7917.ES.2021.26.17.2100430 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Kari Johansen Hanna Nohynek Source Type: research

Socioeconomic deprivation is inversely associated with measles incidence:  a longitudinal small-area analysis, Germany, 2001 to 2017
ConclusionSocioeconomic deprivation in Germany, one of Europe's most populated countries, is inversely associated with measles incidence. This association persists after demographic and spatiotemporal factors are considered. The social, spatial and temporal patterns of elevated risk require targeted public health action and policy to address the complexity underlying measles epidemiology.PMID:33928902 | DOI:10.2807/1560-7917.ES.2021.26.17.1900755 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sven Rohleder Christian Stock Kayvan Bozorgmehr Source Type: research

Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100420.ABSTRACTData on effectiveness of the BioNTech-/Pfizer COVID-19 vaccine in real-world settings are limited. In a study of 6,423 healthcare workers in Treviso Province, Italy, we estimated that, within the time intervals of 14-21 days from the first and at least 7 days from the second dose, vaccine effectiveness in preventing SARS-CoV-2 infection was 84% (95% confidence interval (CI): 40-96) and 95% (95% CI: 62-99), respectively. These results could support the ongoing vaccination campaigns by providing evidence for targeted communication.PMID:33928...
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Massimo Fabiani Mauro Ramigni Valentina Gobbetto Alberto Mateo-Urdiales Patrizio Pezzotti Cinzia Piovesan Source Type: research

National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines
We described existing programmes and used multivariable regression to identify independent factors associated with having them.ResultsOf 194 WHO Member States, 120 (62%) reported having at least one adult immunisation programme. The Americas and Europe had the highest proportions of adult immunisation programmes, most commonly for hepatitis B and influenza vaccines (> 47% and> 91% of countries, respectively), while Africa and South-East Asia had the lowest proportions, with
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sarah R Williams Amanda J Driscoll Hanna M LeBuhn Wilbur H Chen Kathleen M Neuzil Justin R Ortiz Source Type: research

Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019
ConclusionThe immunity gaps found primarily in young HCW indicate a need for a screening and vaccination strategy for this group. Considering the poor correlation between self-reported immunity and seropositivity, efforts should be made to check HCW's immune status in order to identify those who would benefit from vaccination.PMID:33928900 | DOI:10.2807/1560-7917.ES.2021.26.17.2001167 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Marie-Louise von Linstow Alex Yde Nielsen Nikolai Kirkby Anna Eltvedt Thilde Nordmann Winther Allan Bybeck Nielsen Didi Bang Anja Poulsen Source Type: research

No country or continent is on its own in the ongoing COVID-19 pandemic
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100430.NO ABSTRACTPMID:33928901 | DOI:10.2807/1560-7917.ES.2021.26.17.2100430 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Kari Johansen Hanna Nohynek Source Type: research

Socioeconomic deprivation is inversely associated with measles incidence:  a longitudinal small-area analysis, Germany, 2001 to 2017
ConclusionSocioeconomic deprivation in Germany, one of Europe's most populated countries, is inversely associated with measles incidence. This association persists after demographic and spatiotemporal factors are considered. The social, spatial and temporal patterns of elevated risk require targeted public health action and policy to address the complexity underlying measles epidemiology.PMID:33928902 | DOI:10.2807/1560-7917.ES.2021.26.17.1900755 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sven Rohleder Christian Stock Kayvan Bozorgmehr Source Type: research

Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100420.ABSTRACTData on effectiveness of the BioNTech-/Pfizer COVID-19 vaccine in real-world settings are limited. In a study of 6,423 healthcare workers in Treviso Province, Italy, we estimated that, within the time intervals of 14-21 days from the first and at least 7 days from the second dose, vaccine effectiveness in preventing SARS-CoV-2 infection was 84% (95% confidence interval (CI): 40-96) and 95% (95% CI: 62-99), respectively. These results could support the ongoing vaccination campaigns by providing evidence for targeted communication.PMID:33928...
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Massimo Fabiani Mauro Ramigni Valentina Gobbetto Alberto Mateo-Urdiales Patrizio Pezzotti Cinzia Piovesan Source Type: research

National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines
We described existing programmes and used multivariable regression to identify independent factors associated with having them.ResultsOf 194 WHO Member States, 120 (62%) reported having at least one adult immunisation programme. The Americas and Europe had the highest proportions of adult immunisation programmes, most commonly for hepatitis B and influenza vaccines (> 47% and> 91% of countries, respectively), while Africa and South-East Asia had the lowest proportions, with
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sarah R Williams Amanda J Driscoll Hanna M LeBuhn Wilbur H Chen Kathleen M Neuzil Justin R Ortiz Source Type: research

Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019
ConclusionThe immunity gaps found primarily in young HCW indicate a need for a screening and vaccination strategy for this group. Considering the poor correlation between self-reported immunity and seropositivity, efforts should be made to check HCW's immune status in order to identify those who would benefit from vaccination.PMID:33928900 | DOI:10.2807/1560-7917.ES.2021.26.17.2001167 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Marie-Louise von Linstow Alex Yde Nielsen Nikolai Kirkby Anna Eltvedt Thilde Nordmann Winther Allan Bybeck Nielsen Didi Bang Anja Poulsen Source Type: research

No country or continent is on its own in the ongoing COVID-19 pandemic
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100430.NO ABSTRACTPMID:33928901 | DOI:10.2807/1560-7917.ES.2021.26.17.2100430 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Kari Johansen Hanna Nohynek Source Type: research

Socioeconomic deprivation is inversely associated with measles incidence:  a longitudinal small-area analysis, Germany, 2001 to 2017
ConclusionSocioeconomic deprivation in Germany, one of Europe's most populated countries, is inversely associated with measles incidence. This association persists after demographic and spatiotemporal factors are considered. The social, spatial and temporal patterns of elevated risk require targeted public health action and policy to address the complexity underlying measles epidemiology.PMID:33928902 | DOI:10.2807/1560-7917.ES.2021.26.17.1900755 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sven Rohleder Christian Stock Kayvan Bozorgmehr Source Type: research

Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100420.ABSTRACTData on effectiveness of the BioNTech-/Pfizer COVID-19 vaccine in real-world settings are limited. In a study of 6,423 healthcare workers in Treviso Province, Italy, we estimated that, within the time intervals of 14-21 days from the first and at least 7 days from the second dose, vaccine effectiveness in preventing SARS-CoV-2 infection was 84% (95% confidence interval (CI): 40-96) and 95% (95% CI: 62-99), respectively. These results could support the ongoing vaccination campaigns by providing evidence for targeted communication.PMID:33928...
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Massimo Fabiani Mauro Ramigni Valentina Gobbetto Alberto Mateo-Urdiales Patrizio Pezzotti Cinzia Piovesan Source Type: research

National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines
We described existing programmes and used multivariable regression to identify independent factors associated with having them.ResultsOf 194 WHO Member States, 120 (62%) reported having at least one adult immunisation programme. The Americas and Europe had the highest proportions of adult immunisation programmes, most commonly for hepatitis B and influenza vaccines (> 47% and> 91% of countries, respectively), while Africa and South-East Asia had the lowest proportions, with
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sarah R Williams Amanda J Driscoll Hanna M LeBuhn Wilbur H Chen Kathleen M Neuzil Justin R Ortiz Source Type: research

Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019
ConclusionThe immunity gaps found primarily in young HCW indicate a need for a screening and vaccination strategy for this group. Considering the poor correlation between self-reported immunity and seropositivity, efforts should be made to check HCW's immune status in order to identify those who would benefit from vaccination.PMID:33928900 | DOI:10.2807/1560-7917.ES.2021.26.17.2001167 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Marie-Louise von Linstow Alex Yde Nielsen Nikolai Kirkby Anna Eltvedt Thilde Nordmann Winther Allan Bybeck Nielsen Didi Bang Anja Poulsen Source Type: research

No country or continent is on its own in the ongoing COVID-19 pandemic
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100430.NO ABSTRACTPMID:33928901 | DOI:10.2807/1560-7917.ES.2021.26.17.2100430 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Kari Johansen Hanna Nohynek Source Type: research

Socioeconomic deprivation is inversely associated with measles incidence:  a longitudinal small-area analysis, Germany, 2001 to 2017
ConclusionSocioeconomic deprivation in Germany, one of Europe's most populated countries, is inversely associated with measles incidence. This association persists after demographic and spatiotemporal factors are considered. The social, spatial and temporal patterns of elevated risk require targeted public health action and policy to address the complexity underlying measles epidemiology.PMID:33928902 | DOI:10.2807/1560-7917.ES.2021.26.17.1900755 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sven Rohleder Christian Stock Kayvan Bozorgmehr Source Type: research

Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100420.ABSTRACTData on effectiveness of the BioNTech-/Pfizer COVID-19 vaccine in real-world settings are limited. In a study of 6,423 healthcare workers in Treviso Province, Italy, we estimated that, within the time intervals of 14-21 days from the first and at least 7 days from the second dose, vaccine effectiveness in preventing SARS-CoV-2 infection was 84% (95% confidence interval (CI): 40-96) and 95% (95% CI: 62-99), respectively. These results could support the ongoing vaccination campaigns by providing evidence for targeted communication.PMID:33928...
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Massimo Fabiani Mauro Ramigni Valentina Gobbetto Alberto Mateo-Urdiales Patrizio Pezzotti Cinzia Piovesan Source Type: research

National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines
We described existing programmes and used multivariable regression to identify independent factors associated with having them.ResultsOf 194 WHO Member States, 120 (62%) reported having at least one adult immunisation programme. The Americas and Europe had the highest proportions of adult immunisation programmes, most commonly for hepatitis B and influenza vaccines (> 47% and> 91% of countries, respectively), while Africa and South-East Asia had the lowest proportions, with
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sarah R Williams Amanda J Driscoll Hanna M LeBuhn Wilbur H Chen Kathleen M Neuzil Justin R Ortiz Source Type: research

Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019
ConclusionThe immunity gaps found primarily in young HCW indicate a need for a screening and vaccination strategy for this group. Considering the poor correlation between self-reported immunity and seropositivity, efforts should be made to check HCW's immune status in order to identify those who would benefit from vaccination.PMID:33928900 | DOI:10.2807/1560-7917.ES.2021.26.17.2001167 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Marie-Louise von Linstow Alex Yde Nielsen Nikolai Kirkby Anna Eltvedt Thilde Nordmann Winther Allan Bybeck Nielsen Didi Bang Anja Poulsen Source Type: research

No country or continent is on its own in the ongoing COVID-19 pandemic
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100430.NO ABSTRACTPMID:33928901 | DOI:10.2807/1560-7917.ES.2021.26.17.2100430 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Kari Johansen Hanna Nohynek Source Type: research

Socioeconomic deprivation is inversely associated with measles incidence:  a longitudinal small-area analysis, Germany, 2001 to 2017
ConclusionSocioeconomic deprivation in Germany, one of Europe's most populated countries, is inversely associated with measles incidence. This association persists after demographic and spatiotemporal factors are considered. The social, spatial and temporal patterns of elevated risk require targeted public health action and policy to address the complexity underlying measles epidemiology.PMID:33928902 | DOI:10.2807/1560-7917.ES.2021.26.17.1900755 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sven Rohleder Christian Stock Kayvan Bozorgmehr Source Type: research

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Euro Surveill. 2021 Apr;26(16):2100348. doi: 10.2807/1560-7917.ES.2021.26.16.2100348.ABSTRACTWe compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).PMID:33890566 | PMC:PM...
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Tjede Funk Anastasia Pharris Gianfranco Spiteri Nick Bundle Angeliki Melidou Michael Carr Gabriel Gonzalez Alejandro Garcia-Leon Fiona Crispie Lois O'Connor Niamh Murphy Jo ël Mossong Anne Vergison Anke K Wienecke-Baldacchino Tamir Abdelrahman Flavia Ric Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Apr;26(16):2104221. doi: 10.2807/1560-7917.ES.2021.26.16.2104221.NO ABSTRACTPMID:33890567 | PMC:PMC8063587 | DOI:10.2807/1560-7917.ES.2021.26.16.2104221 (Source: Euro Surveill)
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
Euro Surveill. 2021 Apr;26(16):2100413. doi: 10.2807/1560-7917.ES.2021.26.16.2100413.ABSTRACTSARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1....
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Sabrina Jungnick Bernhard Hobmaier Lena Mautner Mona Hoyos Maren Haase Armin Baiker Heidi Lahne Ute Eberle Clara Wimmer Sabrina Hepner Annika Sprenger Carola Berger Alexandra Dangel Manfred Wildner Bernhard Liebl Nikolaus Ackermann Andreas Sing Volker Fin Source Type: research

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Euro Surveill. 2021 Apr;26(16):2100348. doi: 10.2807/1560-7917.ES.2021.26.16.2100348.ABSTRACTWe compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).PMID:33890566 | PMC:PM...
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Tjede Funk Anastasia Pharris Gianfranco Spiteri Nick Bundle Angeliki Melidou Michael Carr Gabriel Gonzalez Alejandro Garcia-Leon Fiona Crispie Lois O'Connor Niamh Murphy Jo ël Mossong Anne Vergison Anke K Wienecke-Baldacchino Tamir Abdelrahman Flavia Ric Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Apr;26(16):2104221. doi: 10.2807/1560-7917.ES.2021.26.16.2104221.NO ABSTRACTPMID:33890567 | PMC:PMC8063587 | DOI:10.2807/1560-7917.ES.2021.26.16.2104221 (Source: Euro Surveill)
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
Euro Surveill. 2021 Apr;26(16):2100413. doi: 10.2807/1560-7917.ES.2021.26.16.2100413.ABSTRACTSARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1....
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Sabrina Jungnick Bernhard Hobmaier Lena Mautner Mona Hoyos Maren Haase Armin Baiker Heidi Lahne Ute Eberle Clara Wimmer Sabrina Hepner Annika Sprenger Carola Berger Alexandra Dangel Manfred Wildner Bernhard Liebl Nikolaus Ackermann Andreas Sing Volker Fin Source Type: research

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100348.ABSTRACTWe compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).PMID:33890566 | DOI:10.2807/15...
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Tjede Funk Anastasia Pharris Gianfranco Spiteri Nick Bundle Angeliki Melidou Michael Carr Gabriel Gonzalez Alejandro Garcia-Leon Fiona Crispie Lois O'Connor Niamh Murphy Jo ël Mossong Anne Vergison Anke K Wienecke-Baldacchino Tamir Abdelrahman Flavia Ric Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2104221.NO ABSTRACTPMID:33890567 | DOI:10.2807/1560-7917.ES.2021.26.16.2104221 (Source: Euro Surveill)
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100413.ABSTRACTSARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1.7 and B....
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Sabrina Jungnick Bernhard Hobmaier Lena Mautner Mona Hoyos Maren Haase Armin Baiker Heidi Lahne Ute Eberle Clara Wimmer Sabrina Hepner Annika Sprenger Carola Berger Alexandra Dangel Manfred Wildner Bernhard Liebl Nikolaus Ackermann Andreas Sing Volker Fin Source Type: research

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100348.ABSTRACTWe compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).PMID:33890566 | DOI:10.2807/15...
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Tjede Funk Anastasia Pharris Gianfranco Spiteri Nick Bundle Angeliki Melidou Michael Carr Gabriel Gonzalez Alejandro Garcia-Leon Fiona Crispie Lois O'Connor Niamh Murphy Jo ël Mossong Anne Vergison Anke K Wienecke-Baldacchino Tamir Abdelrahman Flavia Ric Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2104221.NO ABSTRACTPMID:33890567 | DOI:10.2807/1560-7917.ES.2021.26.16.2104221 (Source: Euro Surveill)
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100413.ABSTRACTSARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1.7 and B....
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Sabrina Jungnick Bernhard Hobmaier Lena Mautner Mona Hoyos Maren Haase Armin Baiker Heidi Lahne Ute Eberle Clara Wimmer Sabrina Hepner Annika Sprenger Carola Berger Alexandra Dangel Manfred Wildner Bernhard Liebl Nikolaus Ackermann Andreas Sing Volker Fin Source Type: research

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100348.ABSTRACTWe compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).PMID:33890566 | DOI:10.2807/15...
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Tjede Funk Anastasia Pharris Gianfranco Spiteri Nick Bundle Angeliki Melidou Michael Carr Gabriel Gonzalez Alejandro Garcia-Leon Fiona Crispie Lois O'Connor Niamh Murphy Jo ël Mossong Anne Vergison Anke K Wienecke-Baldacchino Tamir Abdelrahman Flavia Ric Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2104221.NO ABSTRACTPMID:33890567 | DOI:10.2807/1560-7917.ES.2021.26.16.2104221 (Source: Euro Surveill)
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100413.ABSTRACTSARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1.7 and B....
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Sabrina Jungnick Bernhard Hobmaier Lena Mautner Mona Hoyos Maren Haase Armin Baiker Heidi Lahne Ute Eberle Clara Wimmer Sabrina Hepner Annika Sprenger Carola Berger Alexandra Dangel Manfred Wildner Bernhard Liebl Nikolaus Ackermann Andreas Sing Volker Fin Source Type: research

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100348.ABSTRACTWe compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).PMID:33890566 | DOI:10.2807/15...
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Tjede Funk Anastasia Pharris Gianfranco Spiteri Nick Bundle Angeliki Melidou Michael Carr Gabriel Gonzalez Alejandro Garcia-Leon Fiona Crispie Lois O'Connor Niamh Murphy Jo ël Mossong Anne Vergison Anke K Wienecke-Baldacchino Tamir Abdelrahman Flavia Ric Source Type: research